The funding test for an established business can be the wrong test for an emerging opportunity. A core investment can point to known customers, familiar costs and a record of demand. An early trial is often meant to discover those things. Requiring it to match the core business’s margins before that work begins can prevent leaders from obtaining the evidence they need to judge it.
This helps explain why disruption is often a resource-allocation problem before it is a technology problem. A company may understand an emerging technology and still assess the business around it using standards built for its current customers. Better forecasting will not help much if the organization will not fund the work that could replace assumptions with evidence.
Why the core wins a reasonable contest
Clayton M. Christensen’s The Innovator’s Dilemma explains a difficulty for successful companies: serving existing customers well can draw investment toward improvements those customers already value, while an offering for a different group struggles to earn support. In their article “Disruptive Technologies: Catching the Wave,” Joseph L. Bower and Christensen framed the leadership challenge as serving tomorrow’s customers while staying focused on today’s. The issue is not simply whether managers notice a technology. Their customers and current economics influence what the company chooses to develop.
Christensen’s disk-drive research helps make the distinction concrete. Established customers valued improvements such as greater capacity. A smaller drive could appeal to a different market even when it looked inferior by the measures that mattered to those customers. Investing in better drives for existing buyers was a defensible decision. The emerging offering had to compete for resources without the same visible demand.
That imbalance can recur in a funding review. A proposal for the core business can point to known buyers, familiar costs and revenue within the planning period. An emerging proposal may identify a customer problem but have little evidence yet of repeat use or affordable delivery. If both must clear the same near-term margin hurdle, the emerging proposal may lose before anyone tests the assumptions that matter most.
At OutcomesLab, we call the pull of money, talent and attention toward established work Resource Gravity. A budget decision is only part of it. An approved trial can stall when a specialist repeatedly returns to urgent core-business work. At the next review, the team has too little evidence to justify another investment. That result should prompt a question: Did the opportunity fail a meaningful test, or did the company fail to run the test it approved?
The distinction matters because a weak early business case is not proof of a hidden opportunity. Leaders need a way to learn without treating uncertainty as either a reason for automatic rejection or permission to spend indefinitely.
Fund the next question, not the whole future
The proposed OutcomesLab response is Dual Allocation Logic: judge established investments and bounded emerging bets by evidence appropriate to each decision. A core-business proposal should make a credible case against known demand and costs. An early opportunity may first need to establish who would use the offering, whether it solves a problem for them and what serving them requires. Both face scrutiny, but they should not be asked to prove the same thing at the same time. This allocation discipline also applies to emerging opportunities that are not disruptive; uncertainty alone is not evidence of disruption.
Take a hypothetical product for customers the core business serves poorly. Before funding a trial, its sponsor would identify a group the team can approach and the questions that will determine the next decision. Do customers use the product more than once? How much work does each delivery take? Which costs arise from learning to serve these customers, and which appear likely to persist? Answers would not prove the eventual market is large. They could show whether a further investment has a sound question to answer.
The commitment must be operational, not just financial. The sponsor would name the people who will run the trial, set a spending limit and choose a review date. If the work depends on a specialist in the core business, that person’s contribution must be agreed in advance. Otherwise, an approved budget can sit unused while immediate customer obligations take priority. The sponsor should know before the trial begins what evidence could justify another stage and what would call for a change or a stop.
At OutcomesLab, we use Optionality to describe preserving a credible future choice. A limited trial can preserve the choice to invest more if the evidence warrants it. It cannot do so if the team lacks the means to learn, or if no one has authority to act on what it learns. Equally, keeping a choice open is not a commitment to keep funding it.
Strategic relevance sets another boundary. A.G. Lafley and Roger L. Martin’s Playing to Win: How Strategy Really Works connects choices about where to compete and how to win with the capabilities and management systems needed to support them. Applied to an emerging trial, that means a sponsor should be able to explain why these customers might matter to the company and what advantage it might build in serving them. An interesting technology, by itself, is not a reason to protect a venture from ordinary competition for resources.
Protect the test, then make a choice
A separate funding path can create its own problem. An emerging team may need technical expertise, customer access or operating capacity from the established business. Isolate it completely and it may lose those advantages. Protect it without an end point and leaders may continue supporting a venture whose evidence no longer justifies the resources it takes.
The useful boundary is specific support for a specific test. The sponsor can reserve defined help from the core business so the emerging team does not have to renegotiate every request. In return, the team must meet its review date, show what happened and state what it needs next. If customers do not use the offering, leaders can stop or reconsider whom it serves. If customers use it but delivery remains costly, they can decide whether a narrower test of the operating model is warranted. Stronger evidence may justify another bounded stage, rather than a full launch.
Leaders may also rationally decline the opportunity. An early market can remain too small, demand may not develop, or the same people may create more value elsewhere. Christensen’s account identifies a pattern that can make incumbents vulnerable; it does not establish that every offering unattractive to the core will become a good business. Changing the test is worthwhile when the opportunity is strategically relevant and a limited commitment can resolve an important uncertainty.
Start with one proposal leaders consider important but keep deferring. Put the criterion blocking it beside the question a limited trial could answer. Then decide whether to commit the people and money through a dated review, what support the core business will provide and who can continue or stop the work. If leaders will not make those commitments, they should be clear that they are declining the opportunity. If they will, they can judge it on evidence it has had a fair chance to produce.